Atlas Trials

Combining Lovastatin and a Parent-Implemented Language Intervention for Fragile X Syndrome

Clinical trial NCT02642653 · COMPLETED

Trial details

NCT number
NCT02642653
Sponsor
University of California, Davis
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Fragile X SyndromeGenetic Diseases
Start date
2016-01-01
Primary completion
2018-07-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.